These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34022103)

  • 1. Lactobacilli reduce recurrences of vaginal candidiasis in pregnant women: a randomized, double-blind, placebo-controlled study.
    Ang XY; Chung FY; Lee BK; Azhar SNA; Sany S; Roslan NS; Ahmad N; Yusof SM; Abdullah N; Nik Ab Rahman NN; Abdul Wahid N; Deris ZZ; Oon CE; Wan Adnan WF; Liong MT
    J Appl Microbiol; 2022 Apr; 132(4):3168-3180. PubMed ID: 34022103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis.
    Ang XY; Roslan NS; Ahmad N; Yusof SM; Abdullah N; Nik Ab Rahman NN; Woon JJ; Teh CS; Todorov SD; Liu G; Liong MT
    Benef Microbes; 2023 Nov; 14(5):421-431. PubMed ID: 38350486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics Reduce Vaginal Candidiasis in Pregnant Women via Modulating Abundance of
    Ang XY; Mageswaran UM; Chung YLF; Lee BK; Azhar SNA; Roslan NS; Saufian IFB; Mustaffa NS; Kalam EM; Ibrahim AF; Abdul Wahid N; Deris ZZ; Oon CE; Adnan WFW; Sany S; Liong MT
    Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of
    Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
    Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New evidence on oral L. plantarum P17630 product in women with history of recurrent vulvovaginal candidiasis (RVVC): a randomized double-blind placebo-controlled study.
    Vladareanu R; Mihu D; Mitran M; Mehedintu C; Boiangiu A; Manolache M; Vladareanu S
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):262-267. PubMed ID: 29364495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.
    Falagas ME; Betsi GI; Athanasiou S
    J Antimicrob Chemother; 2006 Aug; 58(2):266-72. PubMed ID: 16790461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
    Russo R; Superti F; Karadja E; De Seta F
    Mycoses; 2019 Apr; 62(4):328-335. PubMed ID: 30565745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
    Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
    Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.
    Ehrström S; Daroczy K; Rylander E; Samuelsson C; Johannesson U; Anzén B; Påhlson C
    Microbes Infect; 2010 Sep; 12(10):691-9. PubMed ID: 20472091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial.
    Gibson CJ; Huang AJ; Larson JC; Mitchell C; Diem S; LaCroix A; Newton KM; Reed SD; Guthrie KA
    Am J Obstet Gynecol; 2020 Jul; 223(1):99.e1-99.e9. PubMed ID: 31954158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial.
    Mollazadeh-Narestan Z; Yavarikia P; Homayouni-Rad A; Samadi Kafil H; Mohammad-Alizadeh-Charandabi S; Gholizadeh P; Mirghafourvand M
    Probiotics Antimicrob Proteins; 2023 Oct; 15(5):1436-1446. PubMed ID: 36198994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertaconazole 300 mg versus clotrimazole 500 mg vaginal suppository for treating pregnant women with acute vaginal candidiasis: a double-blinded, randomized trial.
    Chayachinda C; Thamkhantho M; Rekhawasin T; Klerdklinhom C
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):235. PubMed ID: 38575932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a lactobacilli-containing gel on vulvovaginal candidosis and the vaginal microbiome.
    Oerlemans EFM; Bellen G; Claes I; Henkens T; Allonsius CN; Wittouck S; van den Broek MFL; Wuyts S; Kiekens F; Donders GGG; Lebeer S
    Sci Rep; 2020 May; 10(1):7976. PubMed ID: 32409699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of
    Decherf A; Dehay E; Boyer M; Clément-Ziza M; Rodriguez B; Legrain-Raspaud S
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
    Rostok M; Hütt P; Rööp T; Smidt I; Štšepetova J; Salumets A; Mändar R
    Benef Microbes; 2019 Apr; 10(4):385-393. PubMed ID: 30882242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs.
    van de Wijgert J; Verwijs MC
    BJOG; 2020 Jan; 127(2):287-299. PubMed ID: 31299136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study.
    Murina F; Graziottin A; Vicariotto F; De Seta F
    J Clin Gastroenterol; 2014; 48 Suppl 1():S102-5. PubMed ID: 25291115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.